Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
2.13
-0.12 (-5.33%)
At close: Jun 27, 2025, 3:59 PM
2.11
-1.17%
After-hours: Jun 27, 2025, 05:50 PM EDT
-5.33% (1D)
| Bid | 1.8 |
| Market Cap | 78.3M |
| Revenue (ttm) | 217.76K |
| Net Income (ttm) | -44.91B |
| EPS (ttm) | -3.15 |
| PE Ratio (ttm) | -0.68 |
| Forward PE | -1.23 |
| Analyst | Hold |
| Ask | 2.44 |
| Volume | 616,061 |
| Avg. Volume (20D) | 628,059 |
| Open | 2.25 |
| Previous Close | 2.25 |
| Day's Range | 2.02 - 2.27 |
| 52-Week Range | 1.42 - 12.33 |
| Beta | 1.31 |
Analyst Forecast
According to 0 analyst ratings, the average rating for INO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Inovio Pharmaceuticals Inc. is scheduled to release its earnings on Aug 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-1.7%
Shares of industrial stocks are trading lower foll...
Unlock content with
Pro Subscription
5 months ago
+18.13%
Shares of vaccine makers are trading higher after the first bird flu death was reporting in the US. Additionally, a recent CDC report noted an increase in acute respiratory illness activity.
1 month ago · seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call TranscriptInovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical O...
